| 英文名称 |
中文名称 |
CAS |
|
9,11-Eplerenone Impurity
|
9,11-依普利酮烯酯杂质 |
95716-70-4 |
|
Apixaban
|
阿哌沙班 |
503612-47-3 |
|
Apixaban Chloro Impurity
|
阿哌沙班氯代杂质 |
1801881-20-8 |
|
Apixaban Ethyl ester Impurity
|
阿哌沙班乙酯杂质 |
503614-91-3 |
|
Apixaban Impurity A (BMS-591455-01)
|
阿哌沙班杂质A |
503614-92-4 |
|
Apixaban Impurity H
|
阿哌沙班杂质H |
545445-44-1 |
|
Bortezomib
|
硼替佐米 |
179324-69-7 |
|
Bortezomib D-phenylalanyl analog Impurity
|
硼替佐米 D-苯丙酰胺杂质 |
|
|
Bortezomib Impurity B
|
硼替佐米杂质B |
114457-94-2 |
|
Bortezomib Impurity F
|
硼替佐米杂质F |
|
|
Bortezomib Intermediate A
|
硼替佐米中间体A |
179324-87-9 |
|
Bortezomib L-phenylalanyl analog Impurity
|
硼替佐米 L-苯丙酰胺杂质 |
|
|
Bortezomib PS-619 Impurity
|
硼替佐米PS-619杂质 |
|
|
Canrenone
|
坎利酮 |
976-71-6 |
|
Cefotetan Disodium
|
头孢替坦二钠 |
74356-00-6 |
|
Cefotetan Disodium S-Oxide Impurity
|
头孢替坦二钠-S-氧化杂质 |
|
|
Clevidipine 3,5-DiMethyl Ester Impurity
|
非洛地平EP杂质B |
91189-59-2 |
|
Clevidipine butyrate
|
丁酸氯维地平 |
167221-71-8 |
|
Clevidipine Butyrate Ethyl Ester Impurity
|
丁酸氯维地平乙酯杂质 |
|
|
Clevidipine Butyrate Impurity A
|
丁酸氯维地平杂质A |
123853-39-4 |
|
Clevidipine Butyrate Impurity E
|
丁酸氯维地平杂质E |
253597-19-2 |
|
Clevidipine Butyrate Impurity H168/79
|
丁酸氯维地平杂质H168/79 |
253597-20-5 |
|
Clevidipine Butyrate Impurity H207/59
|
丁酸氯维地平杂质H207/59 |
105383-68-4 |
|
Clevidipine Butyrate Impurity I
|
丁酸氯维地平杂质I |
138279-32-0 |
|
Clevidipine Butyrate Impurity J
|
丁酸氯维地平杂质J |
175688-79-6 |
|
Dabigatran etexilate
|
达比加群酯 |
211915-06-9 |
|
Dabigatran etexilate mesylate
|
甲磺酸达比加群酯 |
872728-81-9 |
|
Dabigatran Impurity A
|
达比加群酯杂质A |
1642853-67-5 |
|
Dabigatran Impurity B
|
达比加群酯杂质B |
1456889-80-7 |
|
Dabigatran Impurity C
|
达比加群酯杂质C |
1408238-36-7 |
|
Dabigatran Impurity D
|
达比加群酯杂质D |
1422435-40-2 |
|
Dabigatran Impurity E
|
达比加群酯杂质E |
1415506-19-2 |
|
Dabigatran Impurity F
|
达比加群酯杂质F |
1422435-41-3 |
|
Dabigatran Impurity H
|
达比加群酯杂质H |
1422495-93-9 |
|
Dabigatran Impurity I
|
达比加群酯杂质I |
1422435-35-5 |
|
Dabigatran Impurity J
|
达比加群酯杂质J |
1580491-16-2 |
|
Dabigatran Impurity K
|
达比加群酯杂质K |
1408238-40-3 |
|
Dabigatran Impurity L
|
达比加群酯杂质L |
211915-00-3 |
|
Dabigatran Impurity O
|
达比加群酯杂质O |
1349500-09-9 |
|
Dabigatran Impurity P
|
达比加群酯杂质P |
|
|
Dabigatran Impurity R
|
达比加群酯杂质R |
1610758-20-7 |
|
Dabigatran Impurity S
|
达比加群酯杂质S |
1415901-84-6 |
|
Desphenyl Tenofovir Alafenamide Impurity
|
替诺福韦艾拉酚胺脱苯基杂质 |
851456-00-3 |
|
Edaravone P1 Impurity
|
依达拉奉P1杂质 |
1357477-99-6 |
|
Edaravone P3 Impurity
|
依达拉奉P3杂质 |
1323485-71-7 |
|
Edaravone Hydroxymethyl Impurity
|
依达拉奉羟甲基杂质 |
1242471-40-4 |
|
Edaravone TriMer Impurity
|
依达拉奉三聚体杂质 |
124009-63-8 |
|
Eplerenone
|
依普利酮 |
107724-20-9 |
|
Eplerenone 7-Carboxylic Acid Impurity
|
依普利酮-7-羧酸杂质 |
209253-82-7 |
|
Eplerenone 9,11-Dihydro Impurity
|
依普利酮-9,11-二氢杂质 |
41020-65-9 |
|
Eplerenone Hydroxyacid Potassium Salt
|
依普利酮羟基酸钾盐 |
95716-98-6 |
|
Methyl pyridine-4-carboxylate N-oxide
|
甲基异烟酸-N-氧化物 |
3783-38-8 |
|
Quetiapine EP Impurity A
|
喹硫平EP杂质A |
844639-07-2 |
|
Quetiapine EP Impurity B
|
喹硫平EP杂质B |
111974-74-4 |
|
Quetiapine EP Impurity C
|
喹硫平EP杂质C |
1798840-31-9 |
|
Quetiapine EP Impurity E
|
喹硫平EP杂质E |
1371638-05-9 |
|
Quetiapine EP Impurity G
|
喹硫平EP杂质G |
3159-07-7 |
|
Quetiapine EP Impurity J
|
喹硫平EP杂质J |
329216-69-5 |
|
Quetiapine EP Impurity L
|
喹硫平EP杂质L |
1371638-11-7 |
|
Quetiapine EP Impurity N
|
喹硫平EP杂质N |
1800291-86-4 |
|
Quetiapine EP Impurity T
|
喹硫平EP杂质T |
5747-46-6 |
|
Quetiapine EP Impurity U
|
喹硫平EP杂质U |
5786-26-5 |
|
Quetiapine EP Impurity V
|
喹硫平EP杂质V |
2204369-14-0 |
|
Quetiapine fumarate
|
富马酸喹硫平 |
111974-72-2 |
|
Rivaroxaban
|
利伐沙班 |
366789-02-8 |
|
Rivaroxaban AcetaMide Impurity
|
利伐沙班乙酰胺杂质 |
1429334-00-8 |
|
Rivaroxaban BenzenedicarboxaMide Impurity
|
利伐沙班苯二甲酰胺杂质 |
1365267-36-2 |
|
Rivaroxaban Dechloro Impurity
|
利伐沙班脱氯杂质 |
1415566-28-7 |
|
Rivaroxaban Diamine Impurity
|
利伐沙班二胺杂质 |
|
|
Rivaroxaban Dichloro Impurity
|
利伐沙班二氯杂质 |
1770812-37-7 |
|
Rivaroxaban Impurity K
|
利伐沙班杂质K |
898543-06-1 |
|
Rivaroxaban Impurity L
|
利伐沙班杂质L |
446292-04-2 |
|
Rivaroxaban Impurity M
|
利伐沙班杂质M |
181140-34-1 |
|
Rivaroxaban Impurity N
|
利伐沙班杂质N |
24065-33-6 |
|
Rivaroxaban Impurity O
|
利伐沙班杂质O |
527-72-0 |
|
Rivaroxaban Impurity P
|
利伐沙班杂质P |
31166-29-7 |
|
Rivaroxaban Phthalimido Descarbonyl Impurity
|
利伐沙班脱羰基杂质 |
446292-07-5 |
|
Rivaroxaban Phthalimido Impurity
|
利伐沙班邻苯二甲酰亚胺杂质 |
446292-08-6 |
|
Rivaroxaban Triamine Impurity
|
利伐沙班三胺杂质 |
|
|
(S)-(+)-GLYCIDYL PHTHALIMIDE
|
(S)-N-缩水甘油邻苯二甲酰亚胺 |
161596-47-0 |
|
11α-HydroxEplerenone Impurity
|
11α-羟基依普利酮杂质 |
192704-56-6 |
|
11α-Hydroxycarvenone
|
11α-羟基坎利酮 |
192569-17-8 |
|
4-(4-Aminophenyl)morpholin-3-one
|
4-(4-氨基苯基)吗啡啉-3-酮 |
438056-69-0 |
|
7β-9,11-Eplerenone Impurity
|
7β-9,11-依普利酮烯酯杂质 |
|
|
Tenofovir Alafenamide
|
替诺福韦艾拉酚胺 |
379270-37-8 |
|
Bortezomib Amide Impurity
|
硼替佐米酰胺杂质 |
289472-80-6 |
|
Apixaban Methyl ester Impurity(BMS-719288-01)
|
阿哌沙班甲酯杂质 |
1074365-84-6 |
|
Bortezomib Impurity E
|
硼替佐米杂质E |
1132709-14-8 |
|
Quetiapine EP Impurity I
|
喹硫平EP杂质I |
329216-67-3 |
|
7β-Eplerenone Impurity
|
7β-依普利酮杂质 |
209253-81-6 |
|
(1S,2R)-Bortezomib Impurity
|
(1S,2R)-硼替佐米杂质 |
1132709-16-0 |
|
(1R,2R)-Bortezomib Impurity
|
(1R,2R)-硼替佐米杂质 |
1132709-15-9 |
|
Rivaroxaban Urea Dimer Impurity
|
利伐沙班尿素二聚体杂质 |
1365267-35-1 |
|
Rivaroxaban R-Isomer Impurity
|
利伐沙班R-异构体杂质 |
865479-71-6 |
|
Quetiapine EP Impurity W
|
喹硫平EP杂质W |
1800608-95-0 |
|
Quetiapine EP Impurity P
|
喹硫平EP杂质P |
1011758-03-4 |
|
Quetiapine EP Impurity H
|
喹硫平EP杂质H |
1076199-40-0 |
|
Quetiapine EP Impurity D
|
喹硫平EP杂质D |
945668-94-0 |
|
Dabigatran Impurity Q
|
达比加群酯杂质Q |
1610758-22-9 |
|
Clevidipine Butyrate Impurity H324/78
|
丁酸氯维地平杂质H324/78 |
188649-48-1 |
